Stabilization of hypoxia-inducible factor-1alpha is involved in the hypoxic stimuli-induced expression of vascular endothelial growth factor in osteoblastic cells.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 11886167)

Published in Cytokine on January 07, 2002

Authors

Hong-Hee Kim1, Shee Eun Lee, Woon Jae Chung, Youngyeon Choi, KyuBum Kwack, Si Wouk Kim, Myong Soo Kim, Hyunsung Park, Zang Hee Lee

Author Affiliations

1: National Research Laboratory for Bone Metabolism, Chosun University, Kwangju, Korea.

Articles by these authors

Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patients. Infect Immun (2003) 2.69

FAM83H mutations in families with autosomal-dominant hypocalcified amelogenesis imperfecta. Am J Hum Genet (2008) 2.38

Digital cameras with designs inspired by the arthropod eye. Nature (2013) 1.77

Regulation of Vibrio vulnificus virulence by the LuxS quorum-sensing system. Mol Microbiol (2003) 1.76

A single recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V. Am J Hum Genet (2012) 1.70

Vibrio vulnificus RTX toxin kills host cells only after contact of the bacteria with host cells. Cell Microbiol (2007) 1.64

CXCL10 promotes osteolytic bone metastasis by enhancing cancer outgrowth and osteoclastogenesis. Cancer Res (2012) 1.55

Monocyclic aromatic hydrocarbon degradation by Rhodococcus sp. strain DK17. Appl Environ Microbiol (2002) 1.48

Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells. Carcinogenesis (2008) 1.46

Expression of inducible nitric oxide synthase in the lower esophageal sphincter of the endotoxemic opossum. J Gastroenterol (2002) 1.40

Reactive oxygen species mediate RANK signaling in osteoclasts. Exp Cell Res (2004) 1.38

A novel flavin-containing monooxygenase from Methylophaga sp strain SK1 and its indigo synthesis in Escherichia coli. Biochem Biophys Res Commun (2003) 1.35

Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1alpha through activation of mitogen-activated protein kinase pathway. J Biol Chem (2003) 1.29

CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice. Circulation (2010) 1.26

Methylophaga aminisulfidivorans sp. nov., a restricted facultatively methylotrophic marine bacterium. Int J Syst Evol Microbiol (2007) 1.21

The F-actin-microtubule crosslinker Shot is a platform for Krasavietz-mediated translational regulation of midline axon repulsion. Development (2007) 1.20

Brain-type creatine kinase has a crucial role in osteoclast-mediated bone resorption. Nat Med (2008) 1.16

Mucosal vaccine adjuvants update. Clin Exp Vaccine Res (2012) 1.15

Association of the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and survival in the Korean population. Mol Carcinog (2012) 1.13

Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway. Biochem Biophys Res Commun (2006) 1.13

Trolox prevents osteoclastogenesis by suppressing RANKL expression and signaling. J Biol Chem (2009) 1.11

Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. Mol Pharmacol (2009) 1.10

Reciprocal cross-talk between RANKL and interferon-gamma-inducible protein 10 is responsible for bone-erosive experimental arthritis. Arthritis Rheum (2008) 1.10

Membrane rafts play a crucial role in receptor activator of nuclear factor kappaB signaling and osteoclast function. J Biol Chem (2003) 1.08

LAMC1 gene is associated with premature ovarian failure. Maturitas (2012) 1.08

Reduction of hypoxia-induced transcription through the repression of hypoxia-inducible factor-1alpha/aryl hydrocarbon receptor nuclear translocator DNA binding by the 90-kDa heat-shock protein inhibitor radicicol. Mol Pharmacol (2002) 1.07

dCIP4 (Drosophila Cdc42-interacting protein 4) restrains synaptic growth by inhibiting the secretion of the retrograde Glass bottom boat signal. J Neurosci (2010) 1.04

Si microwire solar cells: improved efficiency with a conformal SiO2 layer. ACS Nano (2013) 1.04

Escherichia coli ribonuclease III activity is downregulated by osmotic stress: consequences for the degradation of bdm mRNA in biofilm formation. Mol Microbiol (2009) 1.03

FGF2 stimulates the proliferation of human mesenchymal stem cells through the transient activation of JNK signaling. FEBS Lett (2009) 1.02

Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. Biochem Pharmacol (2013) 1.01

Stra13/DEC1 and DEC2 inhibit sterol regulatory element binding protein-1c in a hypoxia-inducible factor-dependent mechanism. Nucleic Acids Res (2008) 1.01

TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-kappaB. J Biochem Mol Biol (2002) 1.00

Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4. J Cell Sci (2006) 1.00

Nitric oxide donor, (+/-)-S-nitroso-N-acetylpenicillamine, stabilizes transactive hypoxia-inducible factor-1alpha by inhibiting von Hippel-Lindau recruitment and asparagine hydroxylation. Mol Pharmacol (2008) 1.00

SNP-SNP interactions between DNA repair genes were associated with breast cancer risk in a Korean population. Cancer (2011) 0.99

Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection. Vaccine (2011) 0.99

Clioquinol, a Cu(II)/Zn(II) chelator, inhibits both ubiquitination and asparagine hydroxylation of hypoxia-inducible factor-1alpha, leading to expression of vascular endothelial growth factor and erythropoietin in normoxic cells. J Biol Chem (2006) 0.98

The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation. J Cell Sci (2008) 0.98

A bacterial RTX toxin causes programmed necrotic cell death through calcium-mediated mitochondrial dysfunction. J Infect Dis (2012) 0.97

Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice. Vaccine (2011) 0.97

Novel function of orphan nuclear receptor Nur77 in stabilizing hypoxia-inducible factor-1alpha. J Biol Chem (2004) 0.97

The interaction between CXCL10 and cytokines in chronic inflammatory arthritis. Autoimmun Rev (2012) 0.97

Modulation of p300 binding by posttranslational modifications of the C-terminal activation domain of hypoxia-inducible factor-1alpha. FEBS Lett (2007) 0.96

RtxA1-induced expression of the small GTPase Rac2 plays a key role in the pathogenicity of Vibrio vulnificus. J Infect Dis (2010) 0.96

Optimization of culture conditions and comparison of biomass productivity of three green algae. Bioprocess Biosyst Eng (2011) 0.95

Suppression of osteoclastogenesis by N,N-dimethyl-D-erythro-sphingosine: a sphingosine kinase inhibition-independent action. Mol Pharmacol (2007) 0.95

Stimulation by TLR5 modulates osteoclast differentiation through STAT1/IFN-beta. J Immunol (2008) 0.94

Grape-seed proanthocyanidin extract as suppressors of bone destruction in inflammatory autoimmune arthritis. PLoS One (2012) 0.94

Histone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcription. J Bone Miner Res (2011) 0.94

NFI-C regulates osteoblast differentiation via control of osterix expression. Stem Cells (2014) 0.94

Microarray analyses of hypoxia-regulated genes in an aryl hydrocarbon receptor nuclear translocator (Arnt)-dependent manner. FEBS J (2008) 0.94

alpha-Lipoic acid inhibits inflammatory bone resorption by suppressing prostaglandin E2 synthesis. J Immunol (2006) 0.93

Plasma membrane calcium ATPase regulates bone mass by fine-tuning osteoclast differentiation and survival. J Cell Biol (2012) 0.93

Chloroform extract of deer antler inhibits osteoclast differentiation and bone resorption. J Ethnopharmacol (2007) 0.93

Essential role of an adenylate cyclase in regulating Vibrio vulnificus virulence. FEMS Microbiol Lett (2005) 0.93

Inhibition of the catalytic activity of hypoxia-inducible factor-1alpha-prolyl-hydroxylase 2 by a MYND-type zinc finger. Mol Pharmacol (2005) 0.92

Draft genome sequence of Methylophaga aminisulfidivorans MP T. J Bacteriol (2011) 0.92

Prevention of CCAAT/enhancer-binding protein beta DNA binding by hypoxia during adipogenesis. J Biol Chem (2009) 0.92

Adenylate cyclase and calmodulin-dependent kinase have opposite effects on osteoclastogenesis by regulating the PKA-NFATc1 pathway. J Bone Miner Res (2011) 0.92

Flagellin enhances tumor-specific CD8⁺ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model. Vaccine (2013) 0.91

Association of sustained ERK activity with integrin beta3 induction during receptor activator of nuclear factor kappaB ligand (RANKL)-directed osteoclast differentiation. Exp Cell Res (2003) 0.91

Hypoxia inhibits adipocyte differentiation in a HDAC-independent manner. Biochem Biophys Res Commun (2005) 0.91

RANKL regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. FASEB J (2003) 0.90

Tanshinone IIA suppresses inflammatory bone loss by inhibiting the synthesis of prostaglandin E2 in osteoblasts. Eur J Pharmacol (2008) 0.90

Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration. Blood (2004) 0.90

The Drosophila homolog of methionine sulfoxide reductase A extends lifespan and increases nuclear localization of FOXO. FEBS Lett (2010) 0.90

Molecular cloning and functional characterization of the genes encoding benzoate and p-hydroxybenzoate degradation by the halophilic Chromohalobacter sp. strain HS-2. FEMS Microbiol Lett (2008) 0.90

α-Tocotrienol inhibits osteoclastic bone resorption by suppressing RANKL expression and signaling and bone resorbing activity. Biochem Biophys Res Commun (2011) 0.90

Hypoxia enhances the expression of prostate-specific antigen by modifying the quantity and catalytic activity of Jumonji C domain-containing histone demethylases. Carcinogenesis (2013) 0.90

Src activates HIF-1α not through direct phosphorylation of HIF-1α specific prolyl-4 hydroxylase 2 but through activation of the NADPH oxidase/Rac pathway. Carcinogenesis (2011) 0.90

Brassinosteroids control AtEXPA5 gene expression in Arabidopsis thaliana. Phytochemistry (2009) 0.90

3D QSAR studies of dioxins and dioxin-like compounds using CoMFA and CoMSIA. Chemosphere (2006) 0.89

Efficient gene delivery in differentiated human embryonic stem cells. Exp Mol Med (2005) 0.89

IL-1alpha stimulation of osteoclast survival through the PI 3-kinase/Akt and ERK pathways. J Biochem (2002) 0.89

Lymph node metastasis of gastric cancer is associated with the interaction between poly (ADP-ribose) polymerase 1 and matrix metallopeptidase 2. DNA Cell Biol (2011) 0.89

Two transactivation domains of hypoxia-inducible factor-1alpha regulated by the MEK-1/p42/p44 MAPK pathway. Mol Cells (2002) 0.89

Genome-wide association studies and epistasis analyses of candidate genes related to age at menarche and age at natural menopause in a Korean population. Menopause (2014) 0.89

Outer membrane vesicles of Vibrio vulnificus deliver cytolysin-hemolysin VvhA into epithelial cells to induce cytotoxicity. Biochem Biophys Res Commun (2010) 0.88

HIF-1-dependent induction of Jumonji domain-containing protein (JMJD) 3 under hypoxic conditions. Mol Cells (2014) 0.88

Involvement of iNOS-dependent NO production in the stimulation of osteoclast survival by TNF-alpha. Exp Cell Res (2004) 0.88

Baicalein induces functional hypoxia-inducible factor-1alpha and angiogenesis. Mol Pharmacol (2008) 0.88

Icariside II from Epimedium koreanum inhibits hypoxia-inducible factor-1alpha in human osteosarcoma cells. Eur J Pharmacol (2007) 0.88

Inhibition of osteoclast differentiation and bone resorption by sauchinone. Biochem Pharmacol (2007) 0.87

Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines: less involvement of metallothionein. Cancer Cell Int (2004) 0.87

A novel zinc finger protein that inhibits osteoclastogenesis and the function of tumor necrosis factor receptor-associated factor 6. J Biol Chem (2001) 0.86

Proteome analysis of differential protein expression in allergen-induced asthmatic mice lung after dexamethasone treatment. Proteomics (2004) 0.86

Crystal structure of the transcriptional activator HlyU from Vibrio vulnificus CMCP6. FEBS Lett (2010) 0.86

Tanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1. Exp Mol Med (2006) 0.86

Genome-wide profiling of antigen-induced time course expression using murine models for acute and chronic asthma. Int Arch Allergy Immunol (2007) 0.86

Overexpression of DRG2 suppresses the growth of Jurkat T cells but does not induce apoptosis. Arch Biochem Biophys (2004) 0.86

Hypoxia-inducible factor-2α-dependent hypoxic induction of Wnt10b expression in adipogenic cells. J Biol Chem (2013) 0.85

cAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction. Biochem Biophys Res Commun (2010) 0.85

AG490, a Jak2-specific inhibitor, induces osteoclast survival by activating the Akt and ERK signaling pathways. Mol Cells (2008) 0.85

Regulation of the ald gene encoding alanine dehydrogenase by AldR in Mycobacterium smegmatis. J Bacteriol (2013) 0.85